Bioavailability of BIBR 953 ZW after 150 mg of BIBR 1048 (oral pro-drug of BIBR 953 ZW) administered as HPMC polymorph II capsule relative to 150 mg HPMC polymorph I capsule in healthy subjects. A two-way, crossover, randomised, open-label trial. Study no. 1160.52. Report no. U05–1125. Boehringer Ingelheim Internal Report - Rathgen, K; Stangier, J; Stähle, H (2005)
et al.